GlassScriptPhysician profile
Haseeba Shahzad
NPI 1770849812
$1,198.51
in general payments reported to CMS, 2019-2025
10 companies · $653 in 2025
The $653 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $346 · 2023: $199 · 2025: $653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $560 · Education: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $559.87 |
| Education | $292.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $224.97 | 2022 | |
| Seagen INC. | $199.94 | 2025 | |
| Genzyme Corporation | $150.00 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $124.74 | 2025 | |
| Janssen Biotech, INC. | $122.66 | 2023-2025 | Erleada |
| Pfizer INC. | $120.12 | 2025 | |
| Novocure INC. | $115.56 | 2025 | Optune Lua (Novottf-200t) |
| Kite Pharma, INC. | $97.47 | 2022 | |
| Janssen Scientific Affairs, LLC | $23.27 | 2022 | |
| Merck Sharp & Dohme LLC | $19.78 | 2023 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haseeba Shahzad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.